Drugs.com
SEPTEMBER 27, 2023
WEDNESDAY, Sept. 27, 2023 -- Ozempic, a type 2 diabetes drug that has increasingly been used to help with weight loss, will now be labeled as having the potential to block intestines. The U.S. Food and Drug Administration recently made the label.
Broad Institute
SEPTEMBER 28, 2023
Scientists reveal cellular changes unique to early Alzheimer’s disease By Allessandra DiCorato September 28, 2023 Breadcrumb Home Scientists reveal cellular changes unique to early Alzheimer’s disease A study of brain tissue from living adults provides a rare look into the earliest stages of the neurodegenerative disease and highlights cell types involved in plaque production.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Drug Hunter
SEPTEMBER 29, 2023
In Wednesday’s Flash Talk webinar, we covered recent highlights in covalent drug discovery, with lots of great questions from the audience. The webinar and recording are available below to everyone thanks to our sponsor, Revvity Signals, and the slides are available for download to Premium members at the bottom. The talk covered: Covalent drugs that break the toxicity stigma Case studies from notable recent covalent molecules Covalent drugs to watch Some of the highlights mentioned in the talk i
Antidote
SEPTEMBER 25, 2023
Clinical trials are how researchers advance their knowledge about potential new treatments, including medications, medical devices, and lifestyle interventions. Clinical trials are divided into phases , each with a distinct duration, purpose, and number of volunteers needed. Before any new treatment becomes available on the market, it must go through this process, as required by the FDA.
Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.
The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven
addgene Blog
SEPTEMBER 28, 2023
Optogenetics gives you the power to control cells or organisms with the flip of a switch. You may be familiar with popular light-sensitive ion channels used to control activities like neuronal signaling — think of a mouse with an LED brain implant or a worm wiggling back and forth under blue light — but there’s a lot more to optogenetics than neuronal activity.
BioPharma Drive: Drug Pricing
SEPTEMBER 25, 2023
Agency scientists flagged numerous issues with Brainstorm’s stem cell treatment ahead of a high-profile Wednesday meeting of expert FDA advisers.
Drug Discovery Digest brings together the best content for drug research and development professionals from the widest variety of industry thought leaders.
Drugs.com
SEPTEMBER 27, 2023
WEDNESDAY, Sept. 27, 2023 -- Just 23% of American adults say they 'definitely' will get the new COVID-19 vaccine, while another 23% say they will 'probably' get it, according to a new poll, which also finds interest in the shot falls along partisan.
Drug Target Review
SEPTEMBER 28, 2023
Can you tell us about your journey in the field of STEM and the challenges you encountered along the way? I started my journey in chemistry – first as an undergraduate and then in my PhD programme at the University of Houston, where I focused on organic chemistry and nucleic acids chemistry. After that, I spent over a decade at a large instrument and genomics company working in, and then leading, research and development.
BioPharma Drive: Drug Pricing
SEPTEMBER 29, 2023
The biotech is expanding cuts it announced a few months ago after the EMA decided against renewing a conditional clearance for its drug Translarna.
KIF1A
SEPTEMBER 23, 2023
#ScienceSaturday posts share exciting scientific developments and educational resources with the KAND community. Each week, Dr. Dylan Verden of KIF1A.ORG summarizes newly published KIF1A-related research and highlights progress in rare disease research and therapeutic development. KIF1A-Related Research RAB3 phosphorylation by pathogenic LRRK2 impairs trafficking of synaptic vesicle precursors During the COVID-19 epidemic many of us experienced how devastating shipping disruptions were; industri
Advertisement
Clinical trial data management is increasingly challenging as studies grow in complexity. Quickly accessing and analyzing study data is vital for assessing trial progress and patient safety. In this paper, we explore real-time data access and analysis for proactive study management. We investigate using adverse event (AE) data to monitor safety and discuss a clinical analytics platform that supports collaboration and data review workflows.
Drugs.com
SEPTEMBER 28, 2023
THURSDAY, Sept. 28, 2023 -- New research shows that an antibiotic effective for bacterial pneumonia also appears to fight treatment-resistant staph infections. The drug is ceftobiprole. It appeared successful in fighting methicillin-resistant staph.
Drug Target Review
SEPTEMBER 26, 2023
Human derived induced pluripotent stem cells (hiPSCs) have revolutionised research and are increasingly used for toxicology screening and disease modelling. Early detection of neurotoxicity induced by potential new therapies is a major challenge, and hiPSC-neuronal cells may provide a solution. These cells demonstrate considerable promise for uncovering drug-induced perturbations to neuronal function such as seizure, and their use extends further to sedation, anti-epileptic drug discovery and mo
BioPharma Drive: Drug Pricing
SEPTEMBER 27, 2023
The Swiss drugmaker is restocking its pipeline by buying into preclinical Ionis medicines for Alzheimer’s and Huntington’s diseases.
Collaborative Drug
SEPTEMBER 28, 2023
Fun with Ketcher New keyboard shortcuts have been added to the structure editor. Cycle through menu options and easily lookup abbreviations while still being able to assign the same atom to multiple locations.
Advertisement
Clinical research has entered a new era, one that requires real-time analytics and visualization to allow trial leaders to work collaboratively and to develop, at the click of a mouse, deep insights that enable proactive study management. Learn how Revvity Signals helps drug developers deliver clinical trial data insights in real-time using a fast and flexible data and analytics platform to empower data-driven decision-making.
Drugs.com
SEPTEMBER 25, 2023
MONDAY, Sept. 25, 2023 -- Having safer neighborhoods, where families feel less stress, can help prevent child abuse, according to new research that supports this long-suspected theory. When parents feel higher levels of stress or hopelessness about.
Drug Patent Watch
SEPTEMBER 25, 2023
“Measuring Patent Value Indicators with Patent Renewal Information” aims to address the research gap by constructing a dynamic model that incorporates both ex ante and ex post patent value indicators.… The post Measuring Patent Value Indicators appeared first on DrugPatentWatch - Make Better Decisions.
BioPharma Drive: Drug Pricing
SEPTEMBER 25, 2023
Eisai and Biogen’s anti-amyloid drug is still undergoing regulatory reviews in the EU, U.K. and elsewhere.
Perficient: Drug Development
SEPTEMBER 26, 2023
In the ever-evolving realm of digital transformation, staying ahead of the curve is paramount. This is where Composable Architecture steps in, reshaping the way businesses construct and manage their digital landscapes. We’re excited to introduce you to two illuminating articles recently featured on CMSWire.com, “The Heart of Composable Architecture,” and “Navigating the Long Tail of Composable in the Martech Landscape” Both articles were penned by Perficient’s own
Advertisement
Clinical development organizations face a wide array of challenges when it comes to data, many of which can impact the operational effectiveness of their clinical trials. In this whitepaper, experts from Revvity Signals explore how solutions like TIBCO® Spotfire® enable better, more streamlined studies. The whitepaper also features a success story from Ambrx, a leading biopharmaceutical company, detailing how it has leveraged Spotfire to tackle data quality and collaboration challenges in clinic
Drugs.com
SEPTEMBER 28, 2023
THURSDAY, Sept. 28, 2023 -- Rabies virus is incurable and almost always fatal once it has invaded the central nervous system, with the victim doomed to suffer a horrible death. But researchers now think they’ve found an effective and simple.
Science Daily: Pharmacology News
SEPTEMBER 28, 2023
Paleontologists discover possible DNA remains in fossil turtle that lived 6 million years ago in Panama, where continents collide.
BioPharma Drive: Drug Pricing
SEPTEMBER 27, 2023
Laboratoires Théa terminated its planned purchase of ProQR’s sepofarsen after certain ProQR personnel opted against working for the French company.
biobide
SEPTEMBER 29, 2023
Within the field of Drug Discovery and Development the term “ New Alternative Methodologies ” (NAMs) refers to the use of new and innovative testing methods that come to replace traditional animal models. In addition to ethical constraints and animal welfare distress regarding the use of animals such as rodents in preclinical testing, there are a number of obstacles encountered in the traditional testing methods.
Drugs.com
SEPTEMBER 28, 2023
THURSDAY, Sept. 28, 2023 – An advisory panel to the U.S. Food and Drug Administration on Wednesday voted resoundingly against recommending, NurOwn, a stem cell-based experimental treatment for ALS. Although the FDA isn't bound by the votes of.
Collaborative Drug
SEPTEMBER 29, 2023
Biotech Networks Scientific Speed Networking: DC Area October 11th 2023
BioPharma Drive: Drug Pricing
SEPTEMBER 27, 2023
Expert advisers to the agency voted 17-1 that Brainstorm's clinical trial data did not show the company's stem cell treatment was effective for treating ALS.
Perficient: Drug Development
SEPTEMBER 28, 2023
I’ve always had an intrapreneurial spirit in the jobs I’ve held. In some roles, I have been given autonomy with the ability to set North Star goals and chase them. In other roles, I’ve found myself building up consensus and bubbling ideas upward. This has involved some tough conversations. If you’ve checked my other blog posts , I tend to focus on innovation , creativity , corporate culture , project management , and organizational change management.
Drugs.com
SEPTEMBER 26, 2023
TUESDAY, Sept. 26, 2023 -- Moms with higher prenatal levels of plastics chemicals known as phthalates may face a slightly increased risk of postpartum depression, according to a new study.
Science Daily: Pharmacology News
SEPTEMBER 25, 2023
The Gulf Stream transport of water through the Florida Strait has slowed by 4% over the past four decades, with a 99% certainty that this weakening is more than expected from random chance, according to a new study.
BioPharma Drive: Drug Pricing
SEPTEMBER 26, 2023
Once valued at more than $7 billion, the liver drug company couldn’t secure a long-sought FDA approval in NASH and last month said it would abandon that research.
On Medicine
SEPTEMBER 27, 2023
Nursing assessments Nursing assessments are the basis for making diagnoses and interventions that meet the needs of the patient. Therefore, any error, lack of information or use of inadequate instruments can affect the next steps in the nursing care process, affecting the quality of care, safety and patient satisfaction. Despite their relevance, nurses perceive nursing assessments as an administrative burden due to the increase in duplicated items.
Drugs.com
SEPTEMBER 27, 2023
WEDNESDAY, Sept. 27, 2023 -- Up to 2 million people in the U.S. experience rapid-fire heartbeats from time to time, and many end up in the hospital for treatment. But an investigational nasal spray may help folks with paroxysmal supraventricular.
Science Daily: Pharmacology News
SEPTEMBER 28, 2023
A new study may provide key answers to how to help people experiencing chronic back pain. The study examined the critical connection between the brain and pain for treating chronic pain. Specifically, they looked at the importance of pain attributions, which are people's beliefs about the underlying causes of their pain, to reduce chronic back pain severity.
BioPharma Drive: Drug Pricing
SEPTEMBER 29, 2023
Shares in the biotech surged on Phase 1 trial results for an oral GLP-1 drug Structure is developing, reflecting investor enthusiasm for the weight loss medicines.
Expert insights. Personalized for you.
124 
Let's personalize your content